lunes, 24 de julio de 2023
Drug Trials Snapshots: LEQVIO (inclisiran)
Drug Trials Snapshots: LEQVIO
(inclisiran)
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-leqvio
LEQVIO is a drug for the treatment of high low-density lipoprotein (LDL) cholesterol, which is sometimes referred to as “bad cholesterol”.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario